Uncommon Cents Investing’s Bristol-Myers Squibb BMY Stock Holding History

Uncommon Cents Investing’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$725K	Sell	12,588 -55	-0.4%	-$3.16K	0.16%	140
2026 Q1	$767K	Buy	12,643 +30	+0.2%	+$1.75K	0.18%	133
2025 Q4	$680K	Buy	12,613 +520	+4%	+$25K	0.16%	134
2025 Q3	$545K	Sell	12,093 -200	-2%	-$9.34K	0.14%	145
2025 Q2	$569K	Sell	12,293 -210	-2%	-$10.3K	0.15%	138
2025 Q1	$763K	Buy	12,503 +13	+0.1%	+$758	0.22%	119
2024 Q4	$706K	Buy	12,490 +90	+0.7%	+$5.03K	0.21%	126
2024 Q3	$642K	Buy	12,400 +305	+3%	+$14.3K	0.18%	136
2024 Q2	$502K	Buy	12,095 +1,790	+17%	+$80.1K	0.16%	144
2024 Q1	$559K	Buy	10,305 +1,260	+14%	+$64.2K	0.17%	134
2023 Q4	$464K	Buy	9,045 +3,715	+70%	+$195K	0.15%	143
2023 Q3	$309K	Buy	+5,330	New	+$327K	0.11%	149

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Uncommon Cents Investing's BMY Position: Q2 2026 in Review

Uncommon Cents Investing reduced its Bristol-Myers Squibb (BMY) stake by 0.44% in Q2 2026, selling an estimated $3.16K and leaving 12,588 shares worth $725K. The position accounts for 0.16% of the portfolio, ranked #140.

Uncommon Cents Investing first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $767K in Q1 2026. 1,126 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Uncommon Cents Investing held 12,588 shares of Bristol-Myers Squibb worth $725K as of Q2 2026.
Uncommon Cents Investing sold 55 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.16K.
Bristol-Myers Squibb made up 0.16% of Uncommon Cents Investing's portfolio in Q2 2026, its #140 holding.
Uncommon Cents Investing first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
Uncommon Cents Investing's Bristol-Myers Squibb position peaked at $767K in Q1 2026.
1,126 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Uncommon Cents Investing's 13F filing for Q2 2026, filed 20 Jul 2026.